These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16551866)

  • 1. Immunotherapy of tumors with protein vaccine based on chicken homologous Tie-2.
    Luo Y; Wen YJ; Ding ZY; Fu CH; Wu Y; Liu JY; Li Q; He QM; Zhao X; Jiang Y; Li J; Deng HX; Kang B; Mao YQ; Wei YQ
    Clin Cancer Res; 2006 Mar; 12(6):1813-9. PubMed ID: 16551866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2.
    Yi T; Wei YQ; Tian L; Zhao X; Li J; Deng HX; Wen YJ; Zou CH; Tan GH; Kan B; Su JM; Jiang Y; Mao YQ; Chen P; Wang YS
    Cancer Gene Ther; 2007 Feb; 14(2):158-64. PubMed ID: 17124509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
    Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
    Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
    Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.
    Liu JY; Wei YQ; Yang L; Zhao X; Tian L; Hou JM; Niu T; Liu F; Jiang Y; Hu B; Wu Y; Su JM; Lou YY; He QM; Wen YJ; Yang JL; Kan B; Mao YQ; Luo F; Peng F
    Blood; 2003 Sep; 102(5):1815-23. PubMed ID: 12750177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model.
    Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
    Immunol Lett; 2007 Nov; 113(2):90-8. PubMed ID: 17913245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B; Lalani AS; Harding TC; Luan B; Koprivnikar K; Huan Tu G; Prell R; VanRoey MJ; Simmons AD; Jooss K
    Clin Cancer Res; 2006 Nov; 12(22):6808-16. PubMed ID: 17121902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
    Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
    Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines.
    Yamaguchi S; Tatsumi T; Takehara T; Sakamori R; Uemura A; Mizushima T; Ohkawa K; Storkus WJ; Hayashi N
    Cancer; 2007 Oct; 110(7):1469-77. PubMed ID: 17685394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self-endoglin-related angiogenesis in two liver cancer models.
    Jiao JG; Li YN; Wang H; Liu Q; Cao JX; Bai RZ; Huang FY
    Dig Liver Dis; 2006 Aug; 38(8):578-87. PubMed ID: 16777500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.
    Popkov M; Jendreyko N; McGavern DB; Rader C; Barbas CF
    Cancer Res; 2005 Feb; 65(3):972-81. PubMed ID: 15705898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of human melanoma tumor growth in severe combined immunodeficient mice by passive transfer of antibodies induced by a high molecular weight melanoma-associated antigen mimotope vaccine.
    Wagner S; Krepler C; Allwardt D; Latzka J; Strommer S; Scheiner O; Pehamberger H; Wiedermann U; Hafner C; Breiteneder H
    Clin Cancer Res; 2008 Dec; 14(24):8178-83. PubMed ID: 19088033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice.
    Song S; Wang F; He X; He Y; Li D; Sun S
    Vaccine; 2007 Jun; 25(25):4853-60. PubMed ID: 17418455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
    Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
    Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
    Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
    J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine.
    Scappaticci FA; Nolan GP
    Anticancer Res; 2003; 23(2B):1165-72. PubMed ID: 12820367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.